Código QR (código de barras bidimensional)

Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database

BackgroundEnfortumab vedotin (EV) is an antibody-drug conjugate (ADC) that has been approved by the FDA for patients with locally advanced or metastatic urothelial carcinoma (UC). This study presents a comprehensive pharmacovigilance analysis of the post-marketing safety profile of EV in the real-wo...

Fuld beskrivelse

Na minha lista:
Principais autores: Mingming Yu, Lijun Zhou, Mengda Cao, Chunmei Ji, Yuanyi Zheng
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2024-08-01
Serier:Frontiers in Immunology
Fag:
enfortumab vedotin
FDA Adverse Event Reporting System
real-world
disproportionality analysis
adverse event
Online adgang:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1397692/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker